HOOK Hookipa Pharma Inc.

Fundamentals / CIK 0001760542 / USD

Hookipa Pharma Inc. reported $9.35M in revenue and a net loss of $73.31M for the trailing twelve months ended March 31, 2025 (down 94.5% year over year), with a -860.2% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open HOOK in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

8 fiscal years (2017 to 2024), reported in USD.

$51.93M$25.96M$0-$80.01MFY 2017 Net Income: -$12.72M2017FY 2018 Revenue: $7.63MFY 2018 Net Income: -$16.24M2018FY 2019 Revenue: $11.94MFY 2019 Net Income: -$43.04M2019FY 2020 Revenue: $19.58MFY 2020 Net Income: -$44.08M2020FY 2021 Revenue: $18.45MFY 2021 Net Income: -$75.67M2021FY 2022 Revenue: $14.25MFY 2022 Net Income: -$64.92M2022FY 2023 Revenue: $20.13MFY 2023 Net Income: -$81.58M2023FY 2024 Revenue: $43.95MFY 2024 Net Income: -$43.50M2024

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $43.95M $20.13M $14.25M $18.45M $19.58M $11.94M $7.63M --
Research & Development $68.51M $86.42M $68.64M $82.85M $54.79M $46.31M $21.96M $9.77M
Operating Income -$51.45M -$97.69M -$73.16M -$81.67M -$53.28M -$51.09M -$21.18M -$14.16M
EBITDA -$48.70M -$94.14M -$69.55M -$77.03M -$49.13M -$48.02M -$20.54M -$13.76M
Interest Income $3.70M $5.29M $1.63M $27K $400K $1.59M $0 --
Interest Expense $2.0K $317K $687K $898K $786K $877K $778K $606K
Income Before Tax -$43.61M -$81.21M -$64.69M -$75.66M -$44.08M -$43.04M -$16.21M -$12.72M
Income Tax Expense -$106K $368K $230K $1.0K $0 $0 $24K $4.0K
Net Income -$43.50M -$81.58M -$64.92M -$75.67M -$44.08M -$43.04M -$16.24M -$12.72M
Basic EPS -$3.47 -$8.63 -$9.91 -$23.00 -$16.90 -$24.10 -$177.60 -$139.50
Diluted EPS -$3.47 -$8.63 -$9.91 -$23.00 -$16.90 -$24.10 -$177.60 -$139.50
Basic Shares Outstanding 12.5M 9.5M 6.6M 3.3M 2.6M 1.8M 91.4K 91.2K
Diluted Shares Outstanding 12.5M 9.5M 6.6M 3.3M 2.6M 1.8M 91.4K 91.2K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $2.00M $1.35M $4.70M $1.29M $36.60M $7.41M $6.87M $2.68M
Research & Development $12.86M $13.03M $15.56M $19.75M $20.17M $21.16M $24.62M $19.71M
Operating Income -$17.87M -$21.46M -$18.64M -$22.46M $11.11M -$30.89M -$22.67M -$21.47M
EBITDA -$17.48M -$20.76M -$17.94M -$21.74M $11.75M -$29.62M -$22.18M -$20.61M
Interest Income $236K $488K $809K $1.07M $1.33M $1.24M $1.57M $1.31M
Interest Expense -- $0 $0 $0 $2.0K $49K $49K $97K
Income Before Tax -$15.43M -$25.06M -$13.84M -$19.09M $14.38M -$24.65M -$19.07M -$18.02M
Income Tax Expense $0 -$106K $0 $0 $0 $164K $0 $0
Net Income -$15.43M -$24.95M -$13.84M -$19.09M $14.38M -$24.82M -$19.07M -$18.02M
Basic EPS -$1.23 -- -$1.10 -$1.52 $1.15 -- -$1.73 -$2.18
Diluted EPS -$1.23 -- -$1.10 -$1.52 $1.14 -- -$1.73 -$2.18
Basic Shares Outstanding 12.5M -- 12.5M 12.5M 12.5M -- 11.0M 8.3M
Diluted Shares Outstanding 12.5M -- 12.5M 12.5M 12.6M -- 11.0M 8.3M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $39.68M $117.1M $112.5M $65.92M $142.7M $113.2M $48.58M
Cash & Short-Term Investments $39.68M $117.1M $112.5M $65.92M $142.7M $113.2M $48.58M
Accounts Receivable, Net $290K $511K $6.53M $6.89M $5.54M $1.54M $4.92M
Total Current Assets $80.67M $147.1M $147.2M $102.1M $171.5M $128.0M $62.31M
Property, Plant & Equipment, Net $179K $7.74M $17.97M $16.35M $6.22M $5.13M $4.34M
Other Non-Current Assets -- $581K $863K $1.37M $1.91M $701K $1.60M
Total Non-Current Assets $1.88M $14.22M $23.26M $23.91M $16.31M $15.73M $5.94M
Total Assets $82.55M $161.3M $170.5M $126.0M $187.8M $143.7M $68.25M
Accounts Payable $8.69M $12.50M $5.49M $8.76M $8.01M $944K $3.66M
Deferred Revenue (Current) $4.76M $14.63M $15.68M $5.54M $3.75M $3.59M $6.62M
Total Current Liabilities $24.65M $41.99M $35.63M $27.65M $21.14M $14.76M $14.70M
Long-Term Debt -- $1.17M $2.85M $6.07M $6.56M $7.30M --
Deferred Revenue (Non-Current) $725K $19.67M $25.66M $21K $784K $72K $1.66M
Other Non-Current Liabilities $5.63M $6.02M $3.42M $2.65M $1.41M $2.23M $3.10M
Total Non-Current Liabilities $6.68M $29.49M $32.30M $8.80M $10.55M $11.09M $9.16M
Total Liabilities $31.33M $71.48M $67.94M $36.45M $31.69M $25.85M $23.85M
Total Debt (incl. Leases) $900K $6.57M $6.86M $11.77M $12.86M $14.90M --
Common Stock -- -- -- -- -- -- $0
Retained Earnings -$412.8M -$369.3M -$287.7M -$222.8M -$147.1M -$103.0M -$59.98M
Accumulated Other Comp. Income -$5.09M -$7.93M -$7.16M -$4.78M -$6.07M -$4.65M -$3.72M
Total Stockholders' Equity $51.21M $89.86M $102.5M $89.59M $156.1M $117.9M -$60.38M
Total Equity $51.21M $89.86M $102.5M $89.59M $156.1M $117.9M -$60.38M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Cash & Cash Equivalents $40.28M $39.68M $59.75M $77.15M $92.75M $117.1M $107.7M $135.6M
Cash & Short-Term Investments $40.28M $39.68M $59.75M $77.15M $92.75M $117.1M $107.7M $135.6M
Accounts Receivable, Net $545K $290K $324K $82K $10.21M $511K $675K $255K
Total Current Assets $60.09M $80.67M $93.16M $107.4M $132.7M $147.1M $139.5M $168.1M
Property, Plant & Equipment, Net $98K $179K $6.86M $7.01M $7.33M $7.74M $20.17M $18.22M
Other Non-Current Assets -- -- -- -- $660K $581K $1.09M $1.00M
Total Non-Current Assets $1.17M $1.88M $16.57M $17.70M $13.16M $14.22M $24.54M $22.97M
Total Assets $61.26M $82.55M $109.7M $125.0M $145.9M $161.3M $164.0M $191.1M
Accounts Payable $3.67M $8.69M $8.96M $11.31M $11.20M $12.50M $8.93M $11.64M
Deferred Revenue (Current) $3.63M $4.76M $5.33M $4.10M $4.65M $14.63M $16.05M $19.71M
Total Current Liabilities $16.64M $24.65M $28.57M $27.83M $29.51M $41.99M $40.58M $46.24M
Long-Term Debt -- -- -- -- $1.14M $1.17M $1.12M $1.16M
Deferred Revenue (Non-Current) $567K $725K $1.68M $1.93M $2.62M $19.67M $23.72M $27.44M
Other Non-Current Liabilities $9.69M $5.63M $6.06M $5.83M $5.87M $6.02M $3.33M $3.44M
Total Non-Current Liabilities $10.54M $6.68M $9.36M $11.15M $11.84M $29.49M $28.38M $32.53M
Total Liabilities $27.18M $31.33M $37.93M $38.98M $41.35M $71.48M $68.96M $78.78M
Total Debt (incl. Leases) $600K $900K $2.80M $4.90M $6.14M $6.57M $3.92M $4.46M
Retained Earnings -$428.2M -$412.8M -$387.8M -$374.0M -$354.9M -$369.3M -$344.4M -$325.4M
Accumulated Other Comp. Income -$6.44M -$5.09M -$8.58M -$7.22M -$7.40M -$7.93M -$6.03M -$7.24M
Total Stockholders' Equity $34.08M $51.21M $71.80M $86.06M $104.5M $89.86M $95.05M $112.3M
Total Equity $34.08M $51.21M $71.80M $86.06M $104.5M $89.86M $95.05M $112.3M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$43.50M -$81.58M -$64.92M -$75.67M -$44.08M -$43.04M -$16.24M -$12.72M
Depreciation & Amortization $2.75M $3.55M $3.60M $4.64M $4.15M $3.07M $640K $398K
Stock-Based Compensation $2.01M $2.35M $5.04M $7.64M $8.66M $5.57M $867K $770K
Change in Receivables $524K $6.18M -$341K -$1.94M -$3.58M -$3.62M -$4.99M --
Change in Payables -$1.57M $6.50M -$2.00M $858K $6.30M $4.20M $3.41M -$1.17M
Operating Cash Flow -$76.98M -$57.52M -$20.00M -$66.02M -$39.34M -$41.73M -$15.00M -$11.91M
Capital Expenditure -$194K -$4.16M -$5.02M -$12.58M -$2.37M -$2.00M -$2.15M -$1.30M
Free Cash Flow -$77.17M -$61.68M -$25.01M -$78.60M -$41.71M -$43.73M -$17.15M -$13.21M
Investing Cash Flow -$194K -$4.16M -$5.02M -$12.58M -$2.37M -$2.00M -$2.15M -$1.30M
Common Stock Issued -- $49.04M $45.69M $203K $42.64M $74.76M $9.0K --
Financing Cash Flow -$1.28M $65.67M $72.27M -$235K $73.42M $109.8M $6.87M $58.89M
Net Change in Cash -$78.45M $3.99M $47.26M -$78.83M $31.71M $66.02M -$10.28M $45.68M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Net Income -$15.43M -$24.95M -$13.84M -$19.09M $14.38M -$24.82M -$19.07M -$18.02M
Depreciation & Amortization $389K $699K $700K $714K $640K $1.28M $487K $866K
Stock-Based Compensation -$353K $865K $939K $459K -$249K $417K $574K $696K
Change in Receivables -$231K -$37K -$184K $10.19M -$9.44M $342K -$419K $118K
Change in Payables -$7.20M $3.52M -$3.84M -$580K -$669K $2.40M -$1.08M $3.63M
Operating Cash Flow $52K -$20.94M -$17.51M -$14.38M -$24.16M -$11.22M -$24.12M -$19.33M
Capital Expenditure -$20K -$2.0K -$31K -$45K -$116K -$422K -$3.02M -$445K
Free Cash Flow $32K -$20.94M -$17.54M -$14.42M -$24.27M -$11.65M -$27.14M -$19.78M
Investing Cash Flow -$20K -$2.0K -$31K -$45K -$116K -$422K -$3.02M -$445K
Common Stock Issued -- -- -- -- -- $21.25M -$395K $28.19M
Financing Cash Flow -- $0 $0 -$1.14M -$135K $21.25M -$659K $45.81M
Net Change in Cash $32K -$20.94M -$17.54M -$15.56M -$24.41M $9.60M -$27.80M $26.04M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -117.1% -485.3% -513.4% -442.7% -272.1% -427.8% -277.6% --
Net Profit Margin -99.0% -405.3% -455.6% -410.2% -225.1% -360.4% -212.8% --
Return on Equity (ROE) -84.9% -90.8% -63.3% -84.5% -28.2% -36.5% -- --
Return on Assets (ROA) -52.7% -50.6% -38.1% -60.0% -23.5% -29.9% -23.8% --
Current Ratio 3.27x 3.50x 4.13x 3.69x 8.11x 8.68x 4.24x --
Quick Ratio 1.62x 2.80x 3.34x 2.63x 7.01x 7.77x 3.64x --
Debt to Equity 0.02x 0.07x 0.07x 0.13x 0.08x 0.13x -- --
Revenue Growth (YoY) +118.3% +41.3% -22.8% -5.8% +64.0% +56.5% -- --
5Y Revenue / Share Growth -47.6% -97.4% -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Operating Margin -860.2% -117.1% -121.8% -124.5% -119.4% -485.3% -391.2% -494.6%
Net Profit Margin -784.0% -99.0% -86.7% -93.2% -88.7% -405.3% -336.1% -429.1%
Return on Equity (ROE) -215.1% -84.9% -60.4% -56.5% -45.5% -90.8% -72.7% -60.8%
Return on Assets (ROA) -119.7% -52.7% -39.5% -38.9% -32.6% -50.6% -42.1% -35.7%
Current Ratio 3.61x 3.27x 3.26x 3.86x 4.50x 3.50x 3.44x 3.64x
Quick Ratio 2.45x 1.62x 2.10x 2.77x 3.49x 2.80x 2.67x 2.94x
Debt to Equity 0.02x 0.02x 0.04x 0.06x 0.06x 0.07x 0.04x 0.04x
Revenue Growth (YoY) -94.5% -81.7% -31.5% -51.8% +1052.4% -5.4% +207.9% -2.4%
Operating Income Growth (YoY) -260.9% -- -- -- -- -- -- --
Net Income Growth (YoY) -207.3% -- -- -- -- -- -- --
EPS Growth (YoY) -207.0% -- -- -- -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -- -- -- -185.4% -- --
Free Cash Flow Growth (YoY) -- -- -- -- -- -192.9% -- --
Source: SEC EDGAR CompanyFacts (CIK 0001760542) · from December 31, 2017 Data through March 31, 2025 · synced Nov 21, 2026, 05:05 UTC · Open in terminal